인문학
사회과학
자연과학
공학
의약학
농수해양학
예술체육학
복합학
DBpia AI
AI 에이전트
AI 아이디어
AI 리더
AI 뷰어
Citeasy
크롬 서지관리 다운로드
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2025.6
- 수록면
- 93 - 104 (12page)
- DOI
- 10.22889/KJP.2025.56.2.93
이용수
초록· 키워드
The peel of Citrus has traditionally been used as a herbal medicine known as Chenpi, with Citrus reticulata officially listed in the Korean Pharmacopoeia for its antioxidant, anti-inflammatory, and digestive benefits. However, much of the Chenpi used in Korea is imported from China, and current pharmacopoeial standards include only C. reticulata and C. unshiu, limiting the use of native Korean citrus varieties. This study aimed to evaluate the potential of Citrus sunki, a native citrus species from Jeju Island, for inclusion in the Korean Pharmacopoeia, based on the Swingle and Tanaka classification systems. The Swingle system, which classifies C. sunki as C. reticulata, was used as a basis to provide scientific evidence for its inclusion through a comparison of their biological activities. DNA sequencing identified the Jeju-native variety Jingyul as C. sunki, while commercial Chenpi products and other Jeju citrus peels were identified as C. reticulata. HPLC analysis showed that C. sunki contained hesperidin levels comparable to or higher than those of C. reticulata. Furthermore, C. sunki demonstrated equivalent or superior antioxidant, skin-whitening, anti-wrinkle, and anti-inflammatory activities. These findings suggest that C. sunki has comparable therapeutic potential to Chenpi, supporting its inclusion in the Korean Pharmacopoeia. The study also underscores the importance of an integrative classification approach considering pharmacological efficacy in evaluating herbal medicines.
상세정보 수정요청해당 페이지 내 제목·저자·목차·페이지정보가 잘못된 경우 알려주세요!
목차
- Abstract
- 재료 및 방법
- 결과
- 고찰
- 결론
- 인용문헌
참고문헌
참고문헌 신청최근 본 자료
UCI(KEPA) : I410-151-25-02-093581259
